XWELL Reports Fiscal 2025 Results
Recent Operating Highlights
- XWELL delivered 2025 revenue of approximately
$29.2 million . - Total operating expenses decreased by approximately 10% versus the comparable prior year period.
- Cost of sales decreased approximately 13% versus 2024.
- General and administrative expenses decreased approximately 20% year-over-year.
- In
December 2025 , the Company opened a new wellness retail location in New York City’sPennsylvania Station . - In
February 2026 , XWELL entered into a strategic partnership with PieQ, an AI and predictive intelligence company, to develop a novelU.S. biosecurity forecasting platform in support of theCenters for Disease Control and Prevention (“CDC”). - In
February 2026 , XWELL announced a private placement resulting in gross proceeds to the Company of approximately$31.3 million , before deducting fees and expenses.
“We continue to execute against our strategic priorities by expanding outside of the airport, diversifying access points and elevating brand relevance,” said
Momentum
During 2025, XWELL achieved multiple milestones that suggest the Company’s momentum in expanding beyond airport terminals and into broader consumer wellness markets. Its new off-airport locations feature a curated selection of health, wellness, and beauty treatments, each intended to deliver the cohesive, elevated, and expert-led XWELL experience to an even wider audience.
In
During the 2025 third quarter, XWELL opened a new wellness center at
To celebrate the
Global Biosecurity Program
Through XpresCheck, XWELL operates at the forefront of global biosecurity.
In March 2025, XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program (“TGS”), operated with the CDC and Ginkgo Bioworks Holdings. The TGS program is designed to provide early detection of emerging pathogens by safeguarding national health through airport-based biosurveillance.
In
In this new role,
Building on its
Liquidity and Financial Condition
As of
Fiscal 2025 Financial Overview
The Company's Annual Report on Form 10-K, including its audited financial statements and Management's Discussion and Analysis of Financial Condition and Results of Operations, is available on XWELL's Investor Relations website at www.xwell.com and on the
- Revenue: Approximately
$29.2 million for the year endedDecember 31, 2025 , consisted of approximately$18.6 million forXpresSpa , approximately$8.3 million for XpresCheck, and approximately$2.3 million for Naples Wax Center. - Total Cost of Sales: Approximately
$21.7 million for the year endedDecember 31, 2025 , compared with approximately$25.0 million in the comparable prior year period. - Total Operating Expenses: Approximately
$23.2 million for the year endedDecember 31, 2025 , compared with approximately$25.6 million in the comparable prior year period. - Operating Loss: Approximately
$15.7 million for the year endedDecember 31, 2025 , compared with approximately$16.7 million in the comparable prior year period. - Net Loss Attributable to XWELL: Approximately
$17.0 million for the year endedDecember 31, 2025 , compared with approximately$16.9 million in the comparable prior year period.
About XWELL, Inc.
Forward-Looking Statements
This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements. Forward-looking statements relating to expectations about future results or events are based upon information available to XWELL as of the date of this press release, and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, as amended, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.
Media Contact:
MWW
htidwell@mww.com
Source: XWELL, Inc.